Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilar Interchangeability Guidance Eliminating Switching Studies Coming Soon
Oct 29 2025
•
By
Cathy Kelly
The US FDA is promoting the growth of US biosimilars market.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics